Brief: Compass Therapeutics Reports Second Quarter 2022 Financial Results And Provides Corporate Update

Compass Therapeutics

01/08/2022 14:41

Aug 1 (Reuters) - Compass Therapeutics Inc.  CMPX.O :
    * COMPASS THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * $132.0 MILLION IN CASH AND MARKETABLE SECURITIES AS OF
JUNE 30,
2022, WITH ANTICIPATED CASH RUNWAY INTO 2H 2024
    * A COMBINATION STUDY OF CTX-471 AND PD-1 BLOCKER IS ON
TRACK TO
INITIATE IN Q4 2022
    * NET LOSS FOR Q2 ENDED JUNE 30, 2022, WAS $8.5 MILLION OR
$0.08
PER COMMON SHARE
    * Q2 EARNINGS PER SHARE VIEW $-0.08 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX38jT3m 
Further company coverage:  CMPX.O 

 ((Reuters.Briefs@thomsonreuters.com;))